• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗肿瘤药。291. 柯里拉京A - 4、A - 5和A - 6(1a)的分离与合成。

Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a).

作者信息

Pettit G R, Singh S B, Boyd M R, Hamel E, Pettit R K, Schmidt J M, Hogan F

机构信息

Cancer Research Institute, Arizona State University, Tempe 85287-1604, USA.

出版信息

J Med Chem. 1995 May 12;38(10):1666-72. doi: 10.1021/jm00010a011.

DOI:10.1021/jm00010a011
PMID:7752190
Abstract

The antineoplastic constituents of Combretum caffrum (Eckl. and Zeyh) Kuntze (Combretaceae family), a species indigenous to South Africa, have been investigated. Subsequently we isolated a series of closely related bibenzyls, stilbenes, and phenanthrenes from C. caffrum. Some of the stilbenes proved to be potent antimitotic agents which inhibited both tubulin polymerization and the binding of colchicine to tubulin. Combretastatin A-4 has been shown to be the most potent cancer cell growth inhibitor of the series. Presently this cis-stilbene is the most effective inhibitor of colchicine binding to tubulin and the simplest natural product yet described with such potent antitubulin effects. Combretastatin A-4, A-5, and A-6 were also found to inhibit growth of Neisseria gonorrhoeae. Details of the isolation and syntheses of combretastatins A-4 (2a), A-5 (2c), and A-6 (3a) have been described.

摘要

南非本土植物南非风车子(使君子科)的抗肿瘤成分已得到研究。随后我们从南非风车子中分离出了一系列密切相关的联苄、芪类化合物和菲类化合物。一些芪类化合物被证明是有效的抗有丝分裂剂,可抑制微管蛋白聚合以及秋水仙碱与微管蛋白的结合。康普瑞他汀A - 4已被证明是该系列中最有效的癌细胞生长抑制剂。目前,这种顺式芪是秋水仙碱与微管蛋白结合的最有效抑制剂,也是迄今所描述的具有如此强大抗微管蛋白作用的最简单天然产物。康普瑞他汀A - 4、A - 5和A - 6还被发现可抑制淋病奈瑟菌的生长。康普瑞他汀A - 4(2a)、A - 5(2c)和A - 6(3a)的分离和合成细节已有描述。

相似文献

1
Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a).抗肿瘤药。291. 柯里拉京A - 4、A - 5和A - 6(1a)的分离与合成。
J Med Chem. 1995 May 12;38(10):1666-72. doi: 10.1021/jm00010a011.
2
Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum.从南非风车子中提取的康普他汀A-1和B-1的分离、结构及合成,这两种物质是微管组装的强效新型抑制剂。
J Nat Prod. 1987 Jan-Feb;50(1):119-31. doi: 10.1021/np50049a016.
3
Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications.康普瑞汀:结构概述、可能的作用机制及潜在应用。
Molecules. 2020 May 31;25(11):2560. doi: 10.3390/molecules25112560.
4
Isolation, structure, synthesis, and antimitotic properties of combretastatins B-3 and B-4 from Combretum caffrum.从南非风车子中分离、鉴定、合成柯里拉京B-3和B-4及其抗有丝分裂特性
J Nat Prod. 1988 May-Jun;51(3):517-27. doi: 10.1021/np50057a011.
5
Antineoplastic agents. 379. Synthesis of phenstatin phosphate.抗肿瘤药。379. 磷酸酚抑素的合成。
J Med Chem. 1998 May 7;41(10):1688-95. doi: 10.1021/jm970644q.
6
Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).抗肿瘤药。509:氟代梳他汀磷酸盐及相关3-卤代芪(1)的合成
J Nat Prod. 2005 Oct;68(10):1450-8. doi: 10.1021/np058038i.
7
Combretastatin A-4 analogues as antimitotic antitumor agents.作为抗有丝分裂抗肿瘤药物的康普瑞他汀A-4类似物。
Curr Med Chem. 2003 Sep;10(17):1697-722. doi: 10.2174/0929867033457151.
8
Development of combretastatins as potent tubulin polymerization inhibitors.作为有效的微管蛋白聚合抑制剂的考布他汀的研发。
Bioorg Chem. 2017 Jun;72:130-147. doi: 10.1016/j.bioorg.2017.04.007. Epub 2017 Apr 17.
9
Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrug.抗肿瘤药393. 康普瑞他汀A-4前药反式异构体的合成。
Anticancer Drug Des. 1998 Dec;13(8):981-93.
10
Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study.微管蛋白与抗有丝分裂剂康普瑞他汀的强效天然及合成类似物的相互作用:一项构效关系研究。
Mol Pharmacol. 1988 Aug;34(2):200-8.

引用本文的文献

1
Targeting Tumor-Associated Hypoxia with Bioreductively Activatable Prodrug Conjugates Derived from Dihydronaphthalene, Benzosuberene, and Indole-based Inhibitors of Tubulin Polymerization.利用源自二氢萘、苯并降冰片烯和基于吲哚的微管蛋白聚合抑制剂的生物可还原激活前药缀合物靶向肿瘤相关缺氧。
RSC Med Chem. 2025 Aug 28. doi: 10.1039/d5md00564g.
2
Alternative Agents to Colcemid for Obtaining High-Quality Metaphase Spreads.用于获得高质量中期染色体铺片的秋水仙酰胺替代剂。
Animals (Basel). 2025 May 20;15(10):1476. doi: 10.3390/ani15101476.
3
Design, synthesis, molecular docking and anticancer activity of benzothiazolecarbohydrazide-sulfonate conjugates: insights into ROS-induced DNA damage and tubulin polymerization inhibition.
苯并噻唑碳酰肼 - 磺酸盐共轭物的设计、合成、分子对接及抗癌活性:对活性氧诱导的DNA损伤和微管蛋白聚合抑制的见解
RSC Adv. 2025 Feb 21;15(8):5895-5905. doi: 10.1039/d4ra07810a. eCollection 2025 Feb 19.
4
First-in-human phase 1 study of an orally bioavailable vascular-disrupting agent DX1002 in patients with advanced solid tumors.口服生物可利用的血管破坏剂DX1002用于晚期实体瘤患者的首次人体1期研究。
Cell Rep Med. 2025 Feb 18;6(2):101969. doi: 10.1016/j.xcrm.2025.101969.
5
()-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer.()-1-(3-(3-羟基-4-甲氧基苯基)-1-(3,4,5-三甲氧基苯基)烯丙基)-1H-1,2,4-三唑及相关化合物:它们作为靶向乳腺癌的新型抗有丝分裂剂的合成与生物学评价
Pharmaceuticals (Basel). 2025 Jan 17;18(1):118. doi: 10.3390/ph18010118.
6
Synthesis and Biological Evaluation of New -Restricted Triazole Analogues of Combretastatin A-4.新的Combretastatin A-4受限三唑类似物的合成与生物学评价
Molecules. 2025 Jan 15;30(2):317. doi: 10.3390/molecules30020317.
7
Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management.近期临床试验及光学控制作为在结直肠癌治疗中开发微管靶向药物的潜在策略。
World J Gastroenterol. 2024 Apr 7;30(13):1780-1790. doi: 10.3748/wjg.v30.i13.1780.
8
3-aryl-4-(3,4,5-trimethoxyphenyl)pyridines inhibit tubulin polymerisation and act as anticancer agents.3-芳基-4-(3,4,5-三甲氧基苯基)吡啶抑制微管蛋白聚合,并具有抗癌作用。
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2286939. doi: 10.1080/14756366.2023.2286939. Epub 2023 Dec 11.
9
Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent.新型柯里拉京衍生物LASSBio-1920作为一种有前景的结直肠癌抗癌药物的药代动力学特征评估。
Pharmaceutics. 2023 Apr 19;15(4):1282. doi: 10.3390/pharmaceutics15041282.
10
Ethnopharmacology, Antimicrobial Potency, and Phytochemistry of African and Species (Combretaceae): A Review.非洲风车子属植物(使君子科)的民族药理学、抗菌效力及植物化学:综述
Antibiotics (Basel). 2023 Jan 28;12(2):264. doi: 10.3390/antibiotics12020264.